Positive results for S3 ad push

New research by UTS involving more than 2000 participants has shown S3 advertising is unlikely to lead to inappropriate use of medicine The Australian Self Medication Industry (ASMI) commissioned the Centre for Health Economic Research and Evaluation (CHERE) at the University of Technology Sydney to conduct research into the impact of consumer advertising for S3

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 9 February 2017
Next Forum: CPD Credits vs Hours